Source-grounded facts extracted from METLIFE INC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
METLIFE INC shareholders approved Advisory (non-binding) vote to approve the compensation paid to the Company's Named Executive Officers at the 2026-06-16 meeting.
“Advisory (non-binding) vote to approve the compensation paid to the Company's Named Executive Officers 519,208,384 29,698,510 1,391,751 42,002,376”
METLIFE INC shareholders approved Ratification of appointment of Deloitte & Touche LLP as the Company's independent auditor for 2026 at the 2026-06-16 meeting.
“Ratification of appointment of Deloitte & Touche LLP as the Company's Independent Auditor for 2026 557,226,053 34,799,734 275,234 N/A”
METLIFE INC shareholders approved Election of eleven directors for a term expiring at the 2027 annual meeting at the 2026-06-16 meeting.
“Election of Directors: Nominee Name Votes For Votes Against Abstained Broker Non-Votes Daniel S. Glaser 548,594,293 1,402,406 301,946 42,002,376 Carla A. Harris 531,093,856 18,882,222 322,567 42,002,376 Laura J. Hay 546,736,903 3,260,345 301,397 42,002,376 R. Glenn Hubbard, Ph.D. 527,371,205 22,608,371 319,069 42,002,376 Jeh C. Johnson 540,643,747 9,327,414 327,484 42,002,376 William E. Kennard 542,209,127 7,782,975 306,543 42,002,376 Michel A. Khalaf 548,618,537 1,357,430 322,678 42,002,376 Diana L. McKenzie 547,213,102 2,800,742 284,801 42,002,376 Christian S. Mumenthaler, Ph.D. 548,665,228 1,315,288 318,129 42,002,376 Michelle Seitz 548,256,661 1,742,224 299,760 42,002,376 Mark A. Weinberger 531,174,670 18,815,797 308,178 42,002,376”
METLIFE INC reported the quarter ended March 31, 2026 results: revenue $14,315, net income $1,140, EPS $1.74 per share.
“otherwise noted. Page 2 of 25 First Quarter 2026 Summary ($ in millions, except per share data) Three Months Ended March 31, 2026 2025 Change Premiums, fees and other revenues $ 14,315 $ 13,639 5% Net investment income 5,355 4,885 10% Net investment gains (losses) (670) (387) Net derivative gains (losses) 74 432 Total revenues $ 19,074 $ 18,569 Adjusted”
METLIFE INC incurred senior notes of $1,000,000,000 aggregate principal amount with The Bank of New York Mellon Trust Company, N.A. at 5.850% Fixed-to-Fixed Reset Rate maturing 2056.
“On February 26, 2026, MetLife, Inc. (the “Company”) issued $1,000,000,000 aggregate principal amount of its 5.850% Fixed-to-Fixed Reset Rate Subordinated Debentures due 2056 (the “Debentures”).”
METLIFE INC: Certificate of Elimination filed to remove Series G Preferred Stock from the Amended and Restated Certificate of Incorporation (effective 2025-10-14).
“On October 14, 2025, MetLife, Inc. (the “Company”) filed a Certificate of Elimination (the “Certificate of Elimination”) with the Secretary of State of the State of Delaware to eliminate its 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G (“the Series G Preferred Stock”), all shares of which the Company previously redeemed, repurchased or otherwise reacquired.”
METLIFE INC incurred senior notes of ¥87,840,000,000 at 2.14%, 2.46%, 2.59%, 2.83%, 3.29%, 3.62% maturing June 17, 2032, June 17, 2035, June 17, 2037, June 17, 2040, June 17, 2045, June 17, 2055.
“On June 17, 2025, MetLife, Inc., a Delaware corporation (the “Company”), entered into a Note Purchase Agreement with the purchasers named therein (the “Purchase Agreement”) in connection with the offer and sale in a private placement of an aggregate principal amount of ¥87,840,000,000 of the Company’s yen-denominated senior notes.”
David L. Herzog resigned as Director at METLIFE INC.
“On March 27, 2025, David L. Herzog, a director of MetLife, Inc. (the “Company”), notified the Company’s Board of Directors (the “Board”) of his decision to resign from the Board, effective May 1, 2025, and not to stand for re-election at the Company’s 2025 annual meeting of shareholders.”
METLIFE INC incurred senior notes of $1,000,000,000 with The Bank of New York Mellon Trust Company, N.A. at 6.350% maturing due 2055.
“On March 13, 2025, MetLife, Inc. (the “Company”) issued $1,000,000,000 aggregate principal amount of its 6.350% Fixed-to-Fixed Reset Rate Subordinated Debentures due 2055”
METLIFE INC incurred senior notes of $1,250,000,000 with 200 Park Funding Trust and The Bank of New York Mellon Trust Company, N.A. at 5.740% maturing February 15, 2055.
“On March 4, 2025 (the “Closing Date”), pursuant to the Purchase Agreement among MetLife, Inc. (the “Company”), 200 Park Funding Trust, a Delaware statutory trust (the “Trust”), and TD Securities (USA) LLC, Barclays Capital Inc., BofA Securities, Inc., Goldman Sachs & Co. LLC and Wells Fargo Securities, LLC, as representatives of the several initial purchasers, the Trust completed the issuance and sale of 1,250,000 of its Pre-Capitalized Trust Securities redeemable February 15, 2055 (the “P-Caps”) for an aggregate purchase price of $1,250,000,000 in private placements pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), as a contingent funding arrangement that provides the Company the right at any time over a thirty-year period to issue its 5.740% Senior Notes due 2055 (the “Senior Notes”) to the Trust, at its election, as described below.”
Christian Mumenthaler was elected as director at METLIFE INC.
“elected Christian Mumenthaler a director of the Company and appointed Mr. Mumenthaler to its Finance and Risk Committee and its Investment Committee, effective May 1, 2025.”
Toby Srihiran Brown was appointed as interim Chief Accounting Officer at METLIFE INC.
“appointed Toby Srihiran Brown, Executive Vice President and Global Head of Reinsurance of the Company, as the Company’s interim Chief Accounting Officer, to be effective as of March 15, 2025”
Tamara L. Schock resigned as Executive Vice President and Chief Accounting Officer at METLIFE INC.
“Tamara L. Schock, notified the Company of her intent to resign as Executive Vice President and Chief Accounting Officer of the Company.”
Tamara L. Schock resigned as Executive Vice President and Chief Accounting Officer at METLIFE INC.
“On January 7, 2025, Tamara L. Schock, Executive Vice President and Chief Accounting Officer of MetLife, Inc. (the “Company”), informed the Company that she would resign from her position to pursue another opportunity.”
METLIFE INC incurred senior notes of ¥15,500,000,000 aggregate principal amount of its 2.195% Senior Notes due 2044 with The Bank of New York Mellon Trust Company, N.A. at 2.195% maturing 2044.
“¥15,500,000,000 aggregate principal amount of its 2.195% Senior Notes due 2044 (the “2044 Senior Notes”)”
METLIFE INC incurred senior notes of ¥11,200,000,000 aggregate principal amount of its 1.953% Senior Notes due 2039 with The Bank of New York Mellon Trust Company, N.A. at 1.953% maturing 2039.
“¥11,200,000,000 aggregate principal amount of its 1.953% Senior Notes due 2039 (the “2039 Senior Notes”)”
METLIFE INC incurred senior notes of ¥16,700,000,000 aggregate principal amount of its 1.670% Senior Notes due 2034 with The Bank of New York Mellon Trust Company, N.A. at 1.670% maturing 2034.
“¥16,700,000,000 aggregate principal amount of its 1.670% Senior Notes due 2034 (the “2034 Senior Notes”)”
METLIFE INC incurred senior notes of ¥23,100,000,000 aggregate principal amount of its 1.415% Senior Notes due 2031 with The Bank of New York Mellon Trust Company, N.A. at 1.415% maturing 2031.
“¥23,100,000,000 aggregate principal amount of its 1.415% Senior Notes due 2031 (the “2031 Senior Notes”)”
METLIFE INC incurred senior notes of ¥7,100,000,000 aggregate principal amount of its 1.009% Senior Notes due 2029 with The Bank of New York Mellon Trust Company, N.A. at 1.009% maturing 2029.
“On March 7, 2024, MetLife, Inc. (the “Company”) issued ¥7,100,000,000 aggregate principal amount of its 1.009% Senior Notes due 2029 (the “2029 Senior Notes”)”
Laura J. Hay was elected as Director at METLIFE INC.
“On February 27, 2024, the Board of Directors (the “Board”) of MetLife, Inc. (the “Company”) elected Laura J. Hay a director of the Company and appointed Ms. Hay to its Audit Committee and its Finance and Risk Committee, effective immediately.”
METLIFE INC reported the quarter and full year ended December 31, 2023 results: net income Net income of $1.4 billion, compared to net income of $5.1 billion for the full year 2022, EPS Net income of $1.81 per share, down 71 percent from the prior year.
“On January 31, 2024, MetLife, Inc. issued (i) a news release announcing its results for the quarter and full year ended December 31, 2023 (the “Earnings Release”), a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference”
METLIFE INC reported third quarter 2023 results: net income $422 million, EPS $0.56 per share.
“MetLife, Inc. (NYSE: MET) today announced its third quarter 2023 results. Third Quarter Results Summary* • Net income of $422 million, or $0.56 per share”
METLIFE INC: Amended and Restated By-Laws to update procedural mechanics for stockholder meetings, nominations, and proposals; clarify board powers; and make other updates (effective 2023-10-03).
“On October 3, 2023, in connection with the new Securities and Exchange Commission rules regarding universal proxy cards, certain recent changes to the Delaware General Corporation Law (the “DGCL”), and a periodic review of the by-laws of MetLife, Inc. (the “Company”), the Company’s board of directors (the “Board”) unanimously adopted Amended and Restated By-Laws of the Company (as so amended and restated, the “Amended and Restated By-Laws”), effective immediately.”
METLIFE INC shareholders approved Advisory vote on frequency of future say-on-pay votes at the 2023-06-20 meeting.
“approximately 99% of the shares voting on the matter voted in favor of an annual frequency for say-on-pay votes”
METLIFE INC incurred senior notes of $1,000,000,000 with The Bank of New York Mellon Trust Company, N.A., as trustee at 5.375% maturing due 2033.
“On July 12, 2023, MetLife, Inc. (the “Company”) issued $1,000,000,000 aggregate principal amount of its 5.375% Senior Notes due 2033 (the “Senior Notes”).”
METLIFE INC shareholders approved Advisory vote on the frequency of future advisory votes to approve the compensation paid to the Company's Named Executive Officers. at the 2023-06-20 meeting.
“1 year 2 years 3 years Abstained Broker Non-Votes Advisory vote on the frequency of future advisory votes to approve the compensation paid to the Company's Named Executive Officers (1) 635,251,006 506,885 5,104,805 798,430 50,118,931”
METLIFE INC shareholders approved Advisory vote to approve the compensation paid to the Company's Named Executive Officers as disclosed in the Company's 2023 Proxy Statement. at the 2023-06-20 meeting.
“Advisory vote to approve the compensation paid to the Company's Named Executive Officers 610,139,897 29,993,247 1,527,981 50,118,931”
METLIFE INC shareholders approved Ratify the appointment of Deloitte & Touche LLP as the Company's independent auditor for 2023. at the 2023-06-20 meeting.
“Ratify the appointment of Deloitte & Touche LLP as the Company's independent auditor for 2023 663,851,986 27,116,219 811,851”
METLIFE INC shareholders approved Election of fourteen Directors, each for a term expiring at the Company's 2024 annual meeting of shareholders. at the 2023-06-20 meeting.
“Election of Directors: Nominee Name Votes For Votes Against Abstained Broker Non-Votes Cheryl W. Grisé 599,352,249 41,746,668 562,208 50,118,931 Carlos M. Gutierrez 636,933,996 4,156,916 570,213 50,118,931 Carla A. Harris 612,731,886 28,362,831 566,408 50,118,931 Gerald L. Hassell 635,132,969 5,962,597 565,559 50,118,931 David L. Herzog 633,890,945 7,142,691 627,489 50,118,931 R. Glenn Hubbard, Ph.D. 613,762,698 27,323,208 575,219 50,118,931 Jeh C. Johnson 639,521,355 1,571,626 568,144 50,118,931 Edward J. Kelly, III 634,972,418 6,118,826 569,881 50,118,931 William E. Kennard 639,450,751 1,629,530 580,844 50,118,931 Michel A. Khalaf 637,285,843 3,803,700 571,582 50,118,931 Catherine R. Kinney 626,099,466 14,978,161 583,498 50,118,931 Diana L. McKenzie 636,408,135 4,703,203 549,787 50,118,931 Denise M. Morrison 628,921,163 11,860,321 879,641 50,118,931 Mark A. Weinberger 631,802,586 9,277,966 580,573 50,118,931”
Steven J. Goulart retired as Executive Vice President and Chief Investment Officer at METLIFE INC.
“On June 16, 2023, Steven J. Goulart, Executive Vice President and Chief Investment Officer of MetLife, Inc. (the “Company”) and a named executive officer in the Company’s most recent proxy statement, informed the Company that he will retire on August 31, 2023.”
METLIFE INC reported first quarter 2023 results: net income Adjusted earnings of $1.2 billion, or $1.52 per share, EPS Adjusted earnings per share $1.52.
“MetLife, Inc. (NYSE: MET) today announced its first quarter 2023 results. First Quarter Results Summary* • Net income of $14 million, or $0.02 per share, compared to net income of $1.6 billion, or $1.89 per share, in the first quarter of 2022.”
Jeh C. Johnson was elected as director at METLIFE INC.
“On February 28, 2023, the Board of Directors (the “Board”) of MetLife, Inc. (the “Company”) increased the number of directors serving on the Board from thirteen to fourteen and elected Jeh C. Johnson a director of the Company and appointed Mr. Johnson to its Audit Committee and its Governance and Corporate Responsibility Committee, effective immediately.”
METLIFE INC reported financial results for quarter ended December 31, 2022.
“On February 1, 2023, MetLife, Inc. issued (i) a news release announcing its results for the quarter and full year ended December 31, 2022 (the "Earnings Release"), a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference,”
METLIFE INC reported financial results for full year ended December 31, 2022.
“On February 1, 2023, MetLife, Inc. issued (i) a news release announcing its results for the quarter and full year ended December 31, 2022 (the "Earnings Release"), a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference,”
METLIFE INC incurred senior notes of $1,000,000,000 with The Bank of New York Mellon Trust Company, N.A. at 5.250% maturing 2054.
“On January 6, 2023, MetLife, Inc. (the “Company”) issued $1,000,000,000 aggregate principal amount of its 5.250% Senior Notes due 2054 (the “Senior Notes”).”
METLIFE INC reported financial results for Third Quarter 2022.
“On November 2, 2022, MetLife, Inc. issued (i) a news release announcing its results for the quarter ended September 30, 2022 (the “Earnings Release”), a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference”
Carla Harris was elected as director at METLIFE INC.
“On April 4, 2022, the Board of Directors (the “Board”) of MetLife, Inc. (the “Company”) increased the number of directors serving on the Board from twelve to thirteen and elected Carla Harris a director of the Company, effective April 27, 2022.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.